ProtAffin Biotechnologie AG We are developing a novel approach within the field of biopharmaceuticals and aims to translate world-class science in understanding of protein-glycan interactions into products addressing medical conditions in respiratory medicine, inflammation and oncology. The company has 24 employees located in Graz, Austria and in Oxford, UK. The Company also has a leading global network of advisors that will support the long-term commercial success of the business.